Gut microbiota linked to sexual preference and HIV infection M Noguera-Julian, M Rocafort, Y Guillén, J Rivera, M Casadellà, P Nowak, ... EBioMedicine 5, 135-146, 2016 | 419 | 2016 |
Detection of SARS-CoV-2 in a cat owned by a COVID-19− affected patient in Spain J Segalés, M Puig, J Rodon, C Avila-Nieto, J Carrillo, G Cantero, ... Proceedings of the National Academy of Sciences 117 (40), 24790-24793, 2020 | 200 | 2020 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 152 | 2022 |
Similarities and differences between the immunopathogenesis of COVID-19–related pediatric multisystem inflammatory syndrome and Kawasaki disease A Esteve-Sole, J Anton, RM Pino-Ramirez, J Sanchez-Manubens, ... The Journal of clinical investigation 131 (6), 2021 | 134 | 2021 |
Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis ER Smith, E Oakley, GW Grandner, K Ferguson, F Farooq, Y Afshar, ... BMJ Global Health 8 (1), e009495, 2023 | 121 | 2023 |
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity J Carrillo, N Izquierdo-Useros, C Ávila-Nieto, E Pradenas, B Clotet, ... Biochemical and Biophysical Research Communications 538, 187-191, 2021 | 119 | 2021 |
Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes R Planas, J Carrillo, A Sanchez, MC Ruiz de Villa, F Nuñez, J Verdaguer, ... Clinical & Experimental Immunology 159 (1), 23-44, 2010 | 116 | 2010 |
Screening NK-, B-and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome M Curriu, J Carrillo, M Massanella, J Rigau, J Alegre, J Puig, ... Journal of translational medicine 11, 1-13, 2013 | 112 | 2013 |
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes E Pradenas, B Trinité, V Urrea, S Marfil, C Ávila-Nieto, ... Med 2 (3), 313-320. e4, 2021 | 110 | 2021 |
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group L De Mattos-Arruda, M Vazquez, F Finotello, R Lepore, E Porta, J Hundal, ... Annals of oncology 31 (8), 978-990, 2020 | 110 | 2020 |
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis ER Smith, E Oakley, GW Grandner, G Rukundo, F Farooq, K Ferguson, ... American journal of obstetrics and gynecology 228 (2), 161-177, 2023 | 108 | 2023 |
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques B Mothe, X Hu, A Llano, M Rosati, A Olvera, V Kulkarni, A Valentin, ... Journal of translational medicine 13, 1-23, 2015 | 106 | 2015 |
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity B Trinité, F Tarrés-Freixas, J Rodon, E Pradenas, V Urrea, S Marfil, ... Scientific Reports 11 (1), 2608, 2021 | 99 | 2021 |
Secreted IgD amplifies humoral T helper 2 cell responses by binding basophils via galectin-9 and CD44 M Shan, J Carrillo, A Yeste, C Gutzeit, D Segura-Garzón, AC Walland, ... Immunity 49 (4), 709-724. e8, 2018 | 99 | 2018 |
Evolution of the gut microbiome following acute HIV-1 infection M Rocafort, M Noguera-Julian, J Rivera, L Pastor, Y Guillén, J Langhorst, ... Microbiome 7, 1-17, 2019 | 97 | 2019 |
Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study M Gonzalez-Cao, T Morán, J Dalmau, J Garcia-Corbacho, JWP Bracht, ... JAMA oncology 6 (7), 1063-1067, 2020 | 96 | 2020 |
Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes S Marin-Gallen, X Clemente-Casares, R Planas, I Pujol-Autonell, ... Clinical & Experimental Immunology 160 (2), 207-214, 2010 | 96 | 2010 |
The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells A Chorny, S Casas-Recasens, J Sintes, M Shan, N Polentarutti, ... Journal of Experimental Medicine 213 (10), 2167-2185, 2016 | 91 | 2016 |
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection Y Guillén, M Noguera-Julian, J Rivera, M Casadellà, AS Zevin, M Rocafort, ... Mucosal immunology 12 (1), 232-246, 2019 | 79 | 2019 |
Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β A Alba, R Planas, X Clemente, J Carrillo, R Ampudia, MC Puertas, ... Clinical & Experimental Immunology 151 (3), 467-475, 2008 | 76 | 2008 |